Market Size of Global Animal Sedative Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 226.15 Million |
Market Size (2029) | USD 299.79 Million |
CAGR (2024 - 2029) | 5.80 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Animal Sedative Market Analysis
The Global Animal Sedative Market size is estimated at USD 226.15 million in 2024, and is expected to reach USD 299.79 million by 2029, growing at a CAGR of 5.80% during the forecast period (2024-2029).
The COVID-19 pandemic significantly impacted the animal sedative market during the initial wave since the veterinary hospital and pharmacy operations were reduced significantly due to several containment measures, such as lockdown and social distancing measures taken by governments across the world. For instance, as per the study published by Faunalytics in December 2022, to avoid disease transmission during the pandemic, around 70% of clinics in the United States and Canada closed their doors to the public, resulting in animals attending visits without their guardians. Also, as per the same source, clinics often ran out of essential supplies. 82% of clinics had pet food, medications, or personal protective equipment shortages. 56% ran out of at least one of those items entirely. Vaccines were in particularly short supply. However, as the pandemic restrictions were eased, the animal sedative market will likely witness growth in the coming years due to the rise in animal surgery cases and the increase in veterinary sedative product launches.
Moreover, the major factors responsible for the growth of the animal sedatives market include a rise in incidences of zoonotic diseases associated with surgical procedures, an increase in the pet population, and growing investment in veterinary product development activities. For instance, 70% of U.S. households, or about 90.5 million families, own a pet, according to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA). Hence, the rise in the pet population indicates an increased concern for pet health. Hence, pet owners will likely invest in pet health care, driving market growth over the forecast period.
Research studies and developments to compare the efficacy of different veterinary sedative products are expected to drive market growth. For instance, as per the article published in December 2022 in Frontiers, a single dosage of romifidine or a combination of romifidine and lidocaine administered epidurally elicited mild to moderate drowsiness and full anti-nociception in the perineal and inguinal regions of donkeys. The technique is convenient for providing analgesia because it is simple, cost-effective, and does not require special or advanced instruments. Hence, such development regarding the utilization of veterinary sedatives is expected to drive market growth over the forecast period.
Additionally, strategic partnerships and product launches by the key players are expected to drive market growth. For instance, in September 2022, Zoetis acquired Jurox, a privately held animal health company that develops, manufactures, and markets a wide range of veterinary medicines for treating livestock and companion animals. Jurox's operations are based in Australia, with additional regional offices in New Zealand, the U.S., Canada, and the U.K. The acquisition of Jurox brings Zoetis a range of important products primed for greater global expansion; a valuable animal health portfolio, including Alfaxan, an anesthetic product for companion animals; and high-quality local R&D and manufacturing operations in Australia, Zoetis' fourth largest market based on revenue in 2021.
Thus, due to the rise in the animal population, an increase in strategic activities by the key players, and an increase in research studies demonstrating the efficacy of sedatives, the studied market is expected to witness notable growth over the forecast period. However, emerging adverse effects of animal sedative drugs, such as respiratory diseases, lowering blood pressure, cardiovascular collapse, etc., and stringent government regulations for sedatives are expected to restrain the market growth over the forecast period.
Animal Sedative Industry Segmentation
As per the report's scope, animal sedatives are drugs used on animals to reduce irritability and excitement. They are CNS depressants that interact with brain activities and decelerate them. They are injected before any medical procedure on animals. The Animal Sedative Market is Segmented by Drug Class (Phenothiazines, Benzodiazepines, alpha-2 adrenergic Receptor Agonists, Butyrophenones, and Other Drug Classes), Application (Surgical, Diagnosis, and Clinical Research Studies), Route of Administration (Oral and Parenteral), Animal Type (Small and Large), and Geography (North America, Europe, Asia Pacific, and Rest of the World). The report offers the value (in USD million) for the above segments.
By Drug Class | |
Phenothiazines | |
Benzodiazepines | |
alpha-2 adrenergic Receptor Agonists | |
Butyrophenones | |
Other Drug Classes |
By Application | |
Surgical | |
Diagnosis | |
Clinical Research Studies |
By Route of Administration | |
Oral | |
Parenteral |
By Animal Type | |
Small | |
Large |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
Rest of the World |
Global Animal Sedative Market Size Summary
The animal sedative market is poised for growth, driven by an increase in pet ownership and a rising demand for veterinary care. The market experienced a downturn during the COVID-19 pandemic due to reduced veterinary operations and supply shortages. However, as restrictions eased, the market began to recover, supported by a surge in animal surgeries and new product launches. Key factors contributing to market expansion include the growing incidence of zoonotic diseases, an expanding pet population, and increased investment in veterinary product development. Research advancements in the efficacy of veterinary sedatives and strategic partnerships among major players further bolster market growth. Despite potential challenges such as adverse effects of sedatives and stringent regulations, the market is expected to witness significant growth over the forecast period.
North America is anticipated to be a significant growth region for the animal sedative market, fueled by rising pet adoption and increased healthcare expenditure for animals. The region's market growth is supported by the prevalence of animal diseases and injuries, alongside a growing awareness of animal health. Strategic initiatives, including mergers, acquisitions, and partnerships, are also contributing to market expansion. The competitive landscape is dominated by major players such as Zoetis Inc., Ceva, and Merck & Co. Inc., who are actively involved in expanding their product offerings and market presence. Overall, the animal sedative market is expected to experience notable growth, driven by a combination of increasing pet ownership, healthcare investments, and strategic industry activities.
Global Animal Sedative Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rise in Incidence of Zoonotic Diseases
-
1.2.2 Increasing Incidence of Animal Cancer
-
1.2.3 Growing Investment in R&D activities to Ensure Quality and Care for Animals
-
-
1.3 Market Restraints
-
1.3.1 Adverse Effects of Animal Sedative Drugs
-
1.3.2 Stringent Government Regulations for the Sedatives
-
-
1.4 Industry Attractiveness - Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Buyers/Consumers
-
1.4.2 Bargaining Power of Suppliers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
2.1 By Drug Class
-
2.1.1 Phenothiazines
-
2.1.2 Benzodiazepines
-
2.1.3 alpha-2 adrenergic Receptor Agonists
-
2.1.4 Butyrophenones
-
2.1.5 Other Drug Classes
-
-
2.2 By Application
-
2.2.1 Surgical
-
2.2.2 Diagnosis
-
2.2.3 Clinical Research Studies
-
-
2.3 By Route of Administration
-
2.3.1 Oral
-
2.3.2 Parenteral
-
-
2.4 By Animal Type
-
2.4.1 Small
-
2.4.2 Large
-
-
2.5 Geography
-
2.5.1 North America
-
2.5.1.1 United States
-
2.5.1.2 Canada
-
2.5.1.3 Mexico
-
-
2.5.2 Europe
-
2.5.2.1 Germany
-
2.5.2.2 United Kingdom
-
2.5.2.3 France
-
2.5.2.4 Italy
-
2.5.2.5 Spain
-
2.5.2.6 Rest of Europe
-
-
2.5.3 Asia Pacific
-
2.5.3.1 China
-
2.5.3.2 Japan
-
2.5.3.3 India
-
2.5.3.4 Australia
-
2.5.3.5 South Korea
-
2.5.3.6 Rest of Asia Pacific
-
-
2.5.4 Rest of the World
-
-
Global Animal Sedative Market Size FAQs
How big is the Global Animal Sedative Market?
The Global Animal Sedative Market size is expected to reach USD 226.15 million in 2024 and grow at a CAGR of 5.80% to reach USD 299.79 million by 2029.
What is the current Global Animal Sedative Market size?
In 2024, the Global Animal Sedative Market size is expected to reach USD 226.15 million.